Mathematical Biosciences and Engineering (MBE)

A simple model of HIV epidemic in Italy: The role of the antiretroviral treatment
Pages: 181 - 207, Issue 1, February 2018

doi:10.3934/mbe.2018008      Abstract        References        Full text (1215.3K)           Related Articles

Federico Papa - Istituto di Analisi dei Sistemi ed Informatica 'A. Ruberti' - CNR, Roma, Italy (email)
Francesca Binda - Dipartimento di Scienze Biomediche e Cliniche 'L. Sacco', Sezione di Malattie Infettive e Immunopatologia, Università degli Studi di Milano, Milano, Italy (email)
Giovanni Felici - Istituto di Analisi dei Sistemi ed Informatica 'A. Ruberti' - CNR, Roma, Italy (email)
Marco Franzetti - Dipartimento di Scienze Biomediche e Cliniche 'L. Sacco', Sezione di Malattie Infettive e Immunopatologia, Università degli Studi di Milano, Milano, Italy (email)
Alberto Gandolfi - Istituto di Analisi dei Sistemi ed Informatica 'A. Ruberti' - CNR, Roma, Italy (email)
Carmela Sinisgalli - Istituto di Analisi dei Sistemi ed Informatica ‘A. Ruberti' - CNR, Roma, Italy (email)
Claudia Balotta - Dipartimento di Scienze Biomediche e Cliniche 'L. Sacco', Sezione di Malattie Infettive e Immunopatologia, Università degli Studi di Milano, Milano, Italy (email)

1 M. Arcà, C. A. Perucci and T. Spadea, The epidemic dynamics of HIV-1 in Italy: Modelling the interaction between intravenous drug users and heterosexual population, Stat Med, 11 (1992), 1657-1684.
2 S. M. Blower, H. B. Gershengorn and R. M. Grant, A tale of two futures: HIV and antiretroviral therapy in San Francisco, Science, 287 (2000), 650-654.
3 C. Bonifazi, F. Heins, S. Strozza and M. Vitiello, The italian transition from emigration to immigration country, IRPPS Working Papers, 24 (2009), 2-91.
4 L. Camoni, S. Boros, V. Regine, M. Ferri and M. Santaquilani et al., Aggiornamento delle nuove diagnosi di infezione da HIV e dei casi di AIDS in Italia al 31 dicembre 2012, Notiziario Istituto Superiore di Sanità, 26 (2013), 3-47.
5 L. Camoni, S. Boros, V. Regine, M. Santaquilani and M. Ferri et al., Aggiornamento delle nuove diagnosi di infezione da HIV e dei casi di AIDS in Italia al 31 dicembre 2013, Notiziario Istituto Superiore di Sanità, 27 (2014), 3-46.
6 L. Camoni, M. Raimondo, M. Dorrucci, V. Regine and M. C. Salfa et al., Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy, AIDS Res Hum Retrov, 31 (2015), 282-287.
7 L. Camoni, V. Regine, K. Stanecki, M. C. Salfa and M. Raimondo et al., Estimates of the number of people living with HIV in Italy, Biomed Res Int, 2014 (2014), Article ID 209619, 6 pages.
8 N. Crepaz, T. A. Hart and G. Marks, Highly active antiretroviral therapy and sexual risk behavior: A meta-analytic review, JAMA-J Am Med Assoc, 292 (2004), 224-236.
9 O. Diekmann, J. A. P. Heesterbeek and J. A. J. Metz, On the definition and the computation of the basic reproduction ratio $R_0$ in models for infectious diseases in heterogeneous populations, J Math Biol, 28 (1990), 365-382.       
10 D. Donnell, J. M. Baeten, J. Kiarie, K. K. Thomas and W. Stevens et al., Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: A prospective cohort analysis, Lancet, 375 (2010), 2092-2098.
11 J. Eaton, N. Menzies, J. Stover, V. Cambiano and L. Chindelevitch et al., Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models, Lancet Glob Health, 2 (2014), e23-e34.
12 M. Franzetti, F. Adorni, C. Parravicini, B. Vergani and S. Antinori et al., Trends and predictors of non-AIDS-defining cancers in men and women with HIV infection: A single-institution retrospective study before and after the introduction of HAART, J Acquir Immune Defic Syndr, 62 (2013), 414-420.
13 M. Franzetti, M. Violin, A. Antinori, A. De Luca and F. Ceccherini-Silberstein et al., Trends and correlates of HIV-1 resistance among subjects failing an antiretroviral treatment over the 2003-2012 decade in Italy, BMC Infect Dis, 14 (2014), p398.
14 R. Granich, S. Crowley, M. Vitoria, Y. R. Lo and Y. Souteyrand et al., Highly active antiretroviral treatment for the prevention of HIV transmission, J Int AIDS Soc, 13 (2010), 1pp.
15 R. M. Granich, C. F. Gilks, C. Dye, K. M. De Cock and B. G. Williams, Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: A mathematical model, Lancet, 373 (2009), 48-57.
16 H. Guo and M. Y. Li, Impacts of migration and immigration on disease transmission dynamics in heterogeneous populations, Discret Contin Dyn S - Series B, 17 (2012), 2413-2430.       
17 H. Guo, M. Y. Li and Z. Shuai, Global stability of the endemic equilibrium of multigroup SIR epidemic models, Canad Appl Math Quart, 14 (2006), 259-284.       
18 H. Guo, M. Y. Li and Z. Shuai, Global dynamics of a general class of multistage models for infectious diseases, SIAM J Appl Math, 72 (2012), 261-279.       
19 M. Iannelli, F. Milner, A. Pugliese and M. Gonzo, The HIV/AIDS epidemics among drug injectors: A study of contact structure through a mathematical model, Math Biosci, 139 (1997), 25-58.
20 S. C. Kalichman, L. Eaton, D. Cain, C. Cherry and H. Pope et al., HIV treatment beliefs and sexual transmission risk behaviors among HIV positive men and women, J Behav Med, 29 (2006), 401-410.
21 M. Kretzschmar, M. Schim van der Loeff, P. Birrell, D. De Angelis and R. Coutinho, Prospects of elimination of HIV with test-and-treat strategy, Proc Natl Acad Sci USA, 110 (2013), 15538-15543.       
22 J. R. Lingappa, J. P. Hughes, R. S. Wang, J. M. Baeten and C. Celum et al., Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk, PLoS One, 5 (2010), e12598.
23 P. M. Luz, B. Grinsztejn, L. Velasque, A. G. Pacheco and V. G. Veloso et al., Long-term CD4+ cell count in response to combination antiretroviral therapy, PLoS One, 9 (2014), e93039.
24 K. A. Lythgoe, L. Pellis and C. Fraser, Is HIV short-sighted? Insights from a multistrain nested model, Evolution, 67 (2013), 2769-2782.
25 R. Manfredi, L. Calza and F. Chiodo, HIV disease among immigrants coming to Italy from outside of the European Union: A case-control study of epidemiological and clinical features, Epidemiol Infect, 127 (2001), 527-533.
26 R. May and R. Anderson, Transmission dynamics of HIV infection, Nature, 326 (1987), 137-142.
27 V. Miller, C. A. Sabin, A. N. Phillips, C. Rottmann and H. Rabenau et al., The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load, AIDS, 14 (2000), 2129-2136.
28 F. Nyabadza, Z. Mukandavire and S. Hove-Musekwa, Modelling the HIV/AIDS epidemic trends in South Africa: Insights from a simple mathematical model, Nonlinear Anal Real World Appl, 12 (2011), 2091-2104.       
29 P. Paci, F. Martini, M. Bernaschi, G. D'Offizi and F. Castiglione, Timely HAART initiation may pave the way for a better viral control, BMC Infect Dis, 11 (2011), p56.
30 M. Parczewski, M. Leszczyszyn-Pynka, M. Witak-Jedra, K. Maciejewska and W. Rymer et al., Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from poland differs by transmission category and subtype, J Antimicrob Chemother, 70 (2015), 233-242.
31 V. Patruno, M. Venturi and S. Roberto, Intercensal Population Estimates. Demographic Balance, National Institute of Statistics of Italy (ISTAT), http://demo.istat.it/index.html.
32 T. C. Quinn, M. J. Wawer, N. Sewankambo, D. Serwadda and C. Li et al., Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group, N Engl J Med, 343 (2000), 921-929.
33 A. S. Rao, K. Thomas, K. Sudhakar and P. K. Maini, HIV/AIDS epidemic in India and predicting the impact of the national response: mathematical modeling and analyis, Math Biosci Eng, 6 (2009), 779-813.       
34 R. J. Smith, J. T. Okano, J. S. Kahn, E. N. Bodine and S. Blower, Evolutionary dynamics of complex networks of HIV drug-resistant strains: The case of San Francisco, Science, 327 (2010), 697-701.
35 T. Sterling, R. E. Chaisson and R. D. Moore, HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy, AIDS, 15 (2001), 2251-2257.
36 B. Taiwo, R. L. Murphy and C. Katlama, Novel antiretroviral combinations in treatment-experienced patients with HIV infection: Rationale and results, Drugs, 70 (2010), 1629-1642.
37 The INSIGHT START Study Group, J. D. Lundgren, A. G. Babiker, F. Gordin and S. Emery et al., Initiation of antiretroviral therapy in early asymptomatic HIV infection, N Engl J Med, 373 (2015), 795-807.
38 P. van den Driessche and J. Watmough, Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission, Math Biosci, 180 (2002), 29-48.       
39 J. Vercauteren, A. M. Wensing, D. A. van de Vijver, J. Albert and C. Balotta et al., Transmission of drug-resistant HIV-1 is stabilizing in europe, J Infect Dis, 200 (2009), 1503-1508.
40 R. Weber, M. Ruppik, M. Rickenbach, A. Spoerri and H. Furrer et al., Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study, HIV Med, 14 (2013), 195-207.
41 When To Start Consortium, J. A. Sterne, M. May, D. Costagliola and F. de Wolf et al., Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: A collaborative analysis of 18 HIV cohort studies, Lancet, 373 (2009), 1352-1363.
42 WHO Guidelines Approved by the Guidelines Review Committee, Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV, World Health Organization, Geneva, 2015.
43 D. P. Wilson, M. G. Law, A. E. Grulich, D. A. Cooper and J. M. Kaldor, Relation between HIV viral load and infectiousness: A model-based analysis, Lancet, 372 (2008), 314-320.
44 T. Zhang, M. Jia, H. Luo, Y. Zhou and N. Wang, Study on a HIV/AIDS model with application to Yunnan province, China, Appl Math Model, 35 (2011), 4379-4392.       
45 M. Zwahlen and M. Egger, Progression and Mortality of Untreated HIV-positive Individuals Living in Resource-Limited Settings: Update of Literature Review and Evidence Synthesis, Report to UNAIDS obligation no HQ/05/422204.

Go to top